Sage Therapeutics, Inc. (SAGE) by event type
SAGE moves most on coverage initiations — a median of +3.01% at 30 minutes across 12 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the SAGE overview →
How SAGE reacts across 5 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 1,905 of 2,717 | 10 | -0.16% | 40% | +1.84% |
| Analyst downgrades 206 of 2,603 | 20 | +0.76% | 65% | +0.72% |
| Coverage initiations 20 of 2,283 | 12 | +3.01% | 67% | -3.72% |
| Rating reiterations 768 of 3,522 | 97 | +0.11% | 53% | +0.47% |
| Price-target cuts 76 of 1,527 | 32 | +0.41% | 66% | +0.07% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how SAGE usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target cuts → · SAGE overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Natera, Inc. (NTRA) | 957 | +0.21% | 57% |
| Antares Pharma, Inc. (ATRS) | 951 | 0.00% | 43% |
| Geron Corporation (GERN) | 949 | -0.28% | 41% |
| Intellia Therapeutics, Inc. (NTLA) | 948 | -0.24% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.